Key result
Multivessel PCI in Bloom syndrome improves LVEF by ~15 points at 6 months.
Why the study?
Surveillance in Bloom syndrome centers on malignancy and metabolic complications, with no previously reported association with CAD or premature myocardial infarction.
Case Report (n=1)
No
This case report describes the first known association between Bloom syndrome and premature multivessel coronary artery disease presenting as STEMI, highlighting the need for increased clinical awareness of cardiovascular disease in this population.
Answers are grounded in this paper and cite their sources.
May prompt CAD evaluation in young Bloom syndrome patients; leaves open whether chromosomal instability accelerates atherogenesis.
Background Bloom syndrome (BSyn) is a rare autosomal recessive chromosomal-instability disorder caused by biallelic BLM variants, in which established surveillance centers on malignancy and metabolic complications. To our knowledge, there is no previously reported association with coronary artery disease (CAD) or premature myocardial infarction. Case summary A 29-year-old man with molecularly confirmed BSyn (c.3415C>T) presented with an anterolateral ST-elevation myocardial infarction six months after unremarkable functional cardiac testing. Coronary angiography revealed total occlusion of the left anterior descending (LAD) artery and two stenoses located in the proximal and mid segments of the right coronary artery (RCA). He underwent rescue percutaneous coronary intervention (PCI) of the LAD, followed by staged PCI of the RCA four weeks later, with the left ventricular ejection fraction recovering from 20–25% at admission to 35–40% at 6-month follow-up. Conclusion The genomic instability that characterizes BSyn may provide a biologically plausible, though unproven, substrate for accelerated atherogenesis, potentially involving vascular smooth muscle cell senescence and cGAS-STING-driven inflammation, that could compound the patient's conventional risk factors. A single case cannot establish causation; however, as supportive care extends survival in BSyn, this case supports increased clinical awareness of premature cardiovascular disease in this population.
No takes yet. Share an insight, caveat, or question.
Adel et al. (2026) conducted a case report in Premature multivessel coronary artery disease and ST-elevation myocardial infarction in Bloom syndrome (n=1). Rescue and staged percutaneous coronary intervention (PCI) was evaluated on Left ventricular ejection fraction (LVEF) recovery at 6-month follow-up. Rescue and staged PCI for premature multivessel CAD in a 29-year-old with Bloom syndrome improved LVEF from 20-25% at admission to 35-40% at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: